- Home
- KRMD vs DHF Comparison
KRMD vs DHF Comparison
Compare KRMD & DHF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KRMD
- DHF
- Stock Information
- Founded
- KRMD 1980
- DHF 1998
- Country
- KRMD United States
- DHF United States
- Employees
- KRMD N/A
- DHF N/A
- Industry
- KRMD Medical/Dental Instruments
- DHF Finance Companies
- Sector
- KRMD Health Care
- DHF Finance
- Exchange
- KRMD Nasdaq
- DHF Nasdaq
- Market Cap
- KRMD 187.5M
- DHF 188.4M
- IPO Year
- KRMD N/A
- DHF N/A
- Fundamental
- Price
- KRMD $4.60
- DHF $2.60
- Analyst Decision
- KRMD Strong Buy
- DHF
- Analyst Count
- KRMD 5
- DHF 0
- Target Price
- KRMD $4.50
- DHF N/A
- AVG Volume (30 Days)
- KRMD 157.7K
- DHF 451.1K
- Earning Date
- KRMD 03-12-2025
- DHF 01-01-0001
- Dividend Yield
- KRMD N/A
- DHF 7.65%
- EPS Growth
- KRMD N/A
- DHF N/A
- EPS
- KRMD N/A
- DHF N/A
- Revenue
- KRMD $31,993,796.00
- DHF N/A
- Revenue This Year
- KRMD $20.04
- DHF N/A
- Revenue Next Year
- KRMD $14.15
- DHF N/A
- P/E Ratio
- KRMD N/A
- DHF N/A
- Revenue Growth
- KRMD 11.57
- DHF N/A
- 52 Week Low
- KRMD $2.01
- DHF $2.06
- 52 Week High
- KRMD $5.05
- DHF $2.39
- Technical
- Relative Strength Index (RSI)
- KRMD 66.80
- DHF 53.08
- Support Level
- KRMD $4.16
- DHF $2.53
- Resistance Level
- KRMD $4.40
- DHF $2.62
- Average True Range (ATR)
- KRMD 0.23
- DHF 0.03
- MACD
- KRMD 0.03
- DHF 0.00
- Stochastic Oscillator
- KRMD 63.71
- DHF 50.00
About KRMD KORU Medical Systems Inc. (DE)
KORU Medical Systems Inc is a developer and manufacturer of medical devices and supplies. It focuses on mechanical infusion products, the FREEDOM Infusion Systems. Its primary products include the Freedom Integrated Infusion System: the FREEDOM60 and FreedomEdge Syringe Drivers, Precision Flow Rate Tubing, HIgH-Flo Subcutaneous Safety Needle Sets, and Precision Flow Rate Tubing. It is a manufacturer of subcutaneous infusion devices that deliver life-saving immunoglobulin therapies to patients with chronic illnesses such as Primary Immunodeficiencies (PIDD) and Chronic Inflammatory Demyelinating Polyneuropathy (CIDP).
About DHF BNY Mellon High Yield Strategies Fund
BNY Mellon High Yield Strategies Fund is a diversified, closed-end management investment company. The fund's primary investment objective is to seek high current income and its secondary objective is capital appreciation. It invests predominantly in fixed-income securities of below-investment-grade credit quality.